Concepedia

M. Rinaldini

MR

6

Publications

850

Citations

6

H-Index

1993

Active since

Affiliations

University of Cagliari(Current)

Azienda Usl 8 Arezzo

M. Rinaldini is an author at University of Cagliari specializing in medicine, oncology, and pharmacotherapy.

Top concepts

MedicineOncologyBreast CancerCancer TherapyPharmacotherapyPharmacologyCancer ResearchHealthSurgeryClinical Trials

Publications per year

1993–2006

6

Publications

6

Switching to Anastrozole Versus Continued Tamoxifen Treatment of Early Breast Cancer: Preliminary Results of the Italian Tamoxifen Anastrozole Trial

Francesco Boccardo, A. Rubagotti, Matteo Puntoni et al. · Journal of Clinical Oncology · 2005 · 448 citations

Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trial

Francesco Boccardo, A. Rubagotti, Pamela Guglielmini et al. · Annals of Oncology · 2006 · 222 citations · Full text

Breast Oncology, Oncology, Tamoxifen Treatment +8

Switching to anastrozole (ANA) vs continued tamoxifen (TAM) treatment of early breast cancer (EBC). Updated results of the Italian tamoxifen anastrozole (ITA) trial

Francesco Boccardo, A. Rubagotti, Matteo Puntoni et al. · Journal of Clinical Oncology · 2005 · 100 citations

Progression-free Survival, Breast Oncology, Distant Metastasis +17

FEC (5-fluorouracil, epidoxorubicin and cyclophosphamide) versus EM (epidoxorubicin and mitomycin-C) with or without lonidamine as first-line treatment for advanced breast cancer. A multicentric randomised study. Final results

P Pacini, M. Rinaldini, R Algeri et al. · European Journal of Cancer · 2000 · 36 citations

Advanced Breast Cancer, Breast Oncology, Medicine +9

Carboplatin and Vinorelbine in the Treatment of Advanced Non-Small-Cell Lung Cancer

Carmine Santomaggio, Enrico Tucci, M. Rinaldini et al. · American Journal of Clinical Oncology · 1998 · 30 citations

Rows per page

1–5 of 6